A Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease
Launched by UNIVERSITY HOSPITALS, LEICESTER · Sep 14, 2012
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
see above
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • measurement of serum creatinine
- • eGFR \< 60 ml/min/1.73m2
About University Hospitals, Leicester
University Hospitals Leicester (UHL) is a leading healthcare provider and clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative clinical studies. As a prominent academic institution, UHL combines cutting-edge clinical practice with rigorous scientific inquiry, facilitating a collaborative environment for researchers, healthcare professionals, and patients. The organization is committed to conducting high-quality, ethically responsible trials across various therapeutic areas, striving to translate research findings into tangible health benefits for the diverse communities it serves. With a strong emphasis on patient safety and effective outcomes, UHL plays a vital role in shaping the future of healthcare through its dedication to clinical excellence and research advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leicester, Leics, United Kingdom
Leicester, Leics, United Kingdom
Leicester, , United Kingdom
Patients applied
Trial Officials
Nigel Brunskill, PhD
Principal Investigator
Consultant
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials